STOCK TITAN

Arvinas, Inc. (NASDAQ: ARVN) Form 144: proposed sale of 3,609 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Arvinas, Inc. submitted a Form 144 notifying the proposed sale of 3,609 shares of common stock in connection with the settlement of vested restricted stock units on 02/23/2026. The filing also reports a prior sale of 4,592 shares on 02/13/2026. The broker listed is Morgan Stanley Smith Barney LLC.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Arvinas's Form 144 report for ARVN?

It reports a proposed sale of 3,609 shares tied to vested RSUs on 02/23/2026. The filing also lists a prior sale of 4,592 shares on 02/13/2026 and names Morgan Stanley Smith Barney LLC as the broker.

Who is the broker handling the transaction in the Form 144?

The broker listed is Morgan Stanley Smith Barney LLC. The filing shows the broker's address as 1 New York Plaza, New York, NY, and associates the proposed 3,609-share transaction with that broker on 02/23/2026.

How many shares were previously sold according to the filing?

The filing records a prior sale of 4,592 shares on 02/13/2026. That past sale amount and date appear under "Securities Sold During The Past 3 Months" for the reporting individual named in the form.

Are the shares being sold from exercised or vested awards?

The 3,609-share proposed sale is tied to settlement of vested restricted stock units. The filing explicitly states "Settlement of vested restricted stock units" with the 02/23/2026 settlement date.

Does the Form 144 indicate proceeds or share price for the sales?

The excerpt provides numeric values but does not label a single, explicit proceeds amount for the proposed sale. The filing lists figures adjacent to rows, but it does not present a clear, labeled aggregate proceeds value for the 3,609-share transaction.
Arvinas

NASDAQ:ARVN

ARVN Rankings

ARVN Latest News

ARVN Latest SEC Filings

ARVN Stock Data

859.32M
59.11M
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW HAVEN